1
|
Exposure to low-dose ionizing radiation from medical imaging procedures.
|
N Engl J Med
|
2009
|
11.51
|
2
|
Strategies for reducing the door-to-balloon time in acute myocardial infarction.
|
N Engl J Med
|
2006
|
8.18
|
3
|
Door-to-balloon time and mortality among patients undergoing primary PCI.
|
N Engl J Med
|
2013
|
8.08
|
4
|
An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure.
|
Circ Cardiovasc Qual Outcomes
|
2008
|
6.00
|
5
|
The obesity paradox: body mass index and outcomes in patients with heart failure.
|
Arch Intern Med
|
2005
|
5.86
|
6
|
Sex-based differences in the effect of digoxin for the treatment of heart failure.
|
N Engl J Med
|
2002
|
5.74
|
7
|
Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission.
|
Circ Cardiovasc Qual Outcomes
|
2009
|
5.66
|
8
|
An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction.
|
Circulation
|
2006
|
5.35
|
9
|
Association of serum digoxin concentration and outcomes in patients with heart failure.
|
JAMA
|
2003
|
5.09
|
10
|
Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality.
|
JAMA
|
2006
|
5.06
|
11
|
An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure.
|
Circulation
|
2006
|
4.52
|
12
|
Risks associated with statin therapy: a systematic overview of randomized clinical trials.
|
Circulation
|
2006
|
4.35
|
13
|
Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator.
|
JAMA
|
2009
|
4.29
|
14
|
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.
|
J Am Coll Cardiol
|
2004
|
4.14
|
15
|
Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction.
|
J Am Coll Cardiol
|
2006
|
4.11
|
16
|
Evaluation of a consumer-oriented internet health care report card: the risk of quality ratings based on mortality data.
|
JAMA
|
2002
|
4.06
|
17
|
Recent national trends in readmission rates after heart failure hospitalization.
|
Circ Heart Fail
|
2009
|
3.95
|
18
|
Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis.
|
Circulation
|
2005
|
3.78
|
19
|
Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction.
|
JAMA
|
2005
|
3.46
|
20
|
Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction.
|
JAMA
|
2004
|
3.45
|
21
|
Long-term prognosis of acute kidney injury after acute myocardial infarction.
|
Arch Intern Med
|
2008
|
3.42
|
22
|
Relationship between heart failure treatment and development of worsening renal function among hospitalized patients.
|
Am Heart J
|
2004
|
3.37
|
23
|
Hospital strategies for reducing risk-standardized mortality rates in acute myocardial infarction.
|
Ann Intern Med
|
2012
|
2.86
|
24
|
Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillance.
|
Arch Intern Med
|
2009
|
2.80
|
25
|
Race, quality of care, and outcomes of elderly patients hospitalized with heart failure.
|
JAMA
|
2003
|
2.77
|
26
|
Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes.
|
Circulation
|
2005
|
2.69
|
27
|
Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study.
|
BMJ
|
2009
|
2.55
|
28
|
National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
|
Circulation
|
2004
|
2.46
|
29
|
Patterns of weight change preceding hospitalization for heart failure.
|
Circulation
|
2007
|
2.45
|
30
|
Driving times and distances to hospitals with percutaneous coronary intervention in the United States: implications for prehospital triage of patients with ST-elevation myocardial infarction.
|
Circulation
|
2006
|
2.40
|
31
|
All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients.
|
J Am Coll Cardiol
|
2009
|
2.40
|
32
|
The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure.
|
J Am Coll Cardiol
|
2003
|
2.34
|
33
|
National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
2.33
|
34
|
Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis.
|
J Am Coll Cardiol
|
2010
|
2.26
|
35
|
The performance of US hospitals as reflected in risk-standardized 30-day mortality and readmission rates for medicare beneficiaries with pneumonia.
|
J Hosp Med
|
2010
|
2.20
|
36
|
Use of medical imaging procedures with ionizing radiation in children: a population-based study.
|
Arch Pediatr Adolesc Med
|
2011
|
2.12
|
37
|
Geriatric conditions and subsequent mortality in older patients with heart failure.
|
J Am Coll Cardiol
|
2010
|
2.07
|
38
|
Effects of age on the quality of care provided to older patients with acute myocardial infarction.
|
Am J Med
|
2003
|
1.89
|
39
|
The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry.
|
J Am Coll Cardiol
|
2010
|
1.87
|
40
|
Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.
|
J Am Coll Cardiol
|
2011
|
1.85
|
41
|
Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.
|
Circulation
|
2005
|
1.83
|
42
|
Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation.
|
Circulation
|
2011
|
1.82
|
43
|
Physician board certification and the care and outcomes of elderly patients with acute myocardial infarction.
|
J Gen Intern Med
|
2006
|
1.82
|
44
|
Regional differences in process of care and outcomes for older acute myocardial infarction patients in the United States and Ontario, Canada.
|
Circulation
|
2006
|
1.78
|
45
|
Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure.
|
Heart Rhythm
|
2010
|
1.74
|
46
|
Quality improvement efforts and hospital performance: rates of beta-blocker prescription after acute myocardial infarction.
|
Med Care
|
2005
|
1.73
|
47
|
Hospital strategies associated with 30-day readmission rates for patients with heart failure.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
1.72
|
48
|
Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project.
|
Am Heart J
|
2006
|
1.69
|
49
|
Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002.
|
J Am Coll Cardiol
|
2005
|
1.69
|
50
|
Acute myocardial infarction and congestive heart failure outcomes at specialty cardiac hospitals.
|
Circulation
|
2007
|
1.61
|
51
|
Trends in acute myocardial infarction in 4 US states between 1992 and 2001: clinical characteristics, quality of care, and outcomes.
|
Circulation
|
2006
|
1.61
|
52
|
Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation.
|
Heart Rhythm
|
2009
|
1.60
|
53
|
Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction.
|
Arch Intern Med
|
2008
|
1.59
|
54
|
Nonsteroidal antiinflammatory drugs after acute myocardial infarction.
|
Am Heart J
|
2002
|
1.58
|
55
|
National efforts to improve door-to-balloon time results from the Door-to-Balloon Alliance.
|
J Am Coll Cardiol
|
2009
|
1.57
|
56
|
Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry.
|
Arch Intern Med
|
2011
|
1.54
|
57
|
Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project.
|
Arch Intern Med
|
2005
|
1.54
|
58
|
Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention.
|
JAMA
|
2013
|
1.51
|
59
|
Use and effectiveness of intra-aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the National Cardiovascular Data Registry.
|
Circ Cardiovasc Qual Outcomes
|
2011
|
1.49
|
60
|
Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance.
|
Heart Rhythm
|
2009
|
1.46
|
61
|
Physician specialty and mortality among elderly patients hospitalized with heart failure.
|
Am J Med
|
2005
|
1.45
|
62
|
Determinants of fluoroscopy time for invasive coronary angiography and percutaneous coronary intervention: insights from the NCDR(®).
|
Catheter Cardiovasc Interv
|
2013
|
1.43
|
63
|
Electrophysiology studies in patients undergoing ICD implantation: findings from the NCDR®.
|
Pacing Clin Electrophysiol
|
2012
|
1.40
|
64
|
Association of door-to-balloon time and mortality in patients > or =65 years with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
|
Am J Cardiol
|
2009
|
1.40
|
65
|
Impact of a recent lead recall on utilization of implantable cardioverter defibrillators: data from the NCDR ICD Registry™.
|
J Cardiovasc Electrophysiol
|
2012
|
1.39
|
66
|
The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011.
|
Heart Rhythm
|
2013
|
1.39
|
67
|
Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures.
|
Heart Rhythm
|
2008
|
1.38
|
68
|
Review of the registry's first year, data collected, and future plans.
|
Heart Rhythm
|
2007
|
1.35
|
69
|
Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
1.35
|
70
|
Ethnic and racial disparities in cardiac resynchronization therapy.
|
Heart Rhythm
|
2008
|
1.32
|
71
|
The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001.
|
Arch Intern Med
|
2005
|
1.32
|
72
|
Sex differences in cardiac catheterization after acute myocardial infarction: the role of procedure appropriateness.
|
Ann Intern Med
|
2002
|
1.31
|
73
|
Variation in hospital mortality rates for patients with acute myocardial infarction.
|
Am J Cardiol
|
2010
|
1.28
|
74
|
National trends in heart failure hospital stay rates, 2001 to 2009.
|
J Am Coll Cardiol
|
2013
|
1.27
|
75
|
Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry.
|
Arch Intern Med
|
2012
|
1.24
|
76
|
The pre-hospital electrocardiogram and time to reperfusion in patients with acute myocardial infarction, 2000-2002: findings from the National Registry of Myocardial Infarction-4.
|
J Am Coll Cardiol
|
2006
|
1.24
|
77
|
Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001.
|
Circulation
|
2005
|
1.24
|
78
|
Quality of care for acute myocardial infarction at urban safety-net hospitals.
|
Health Aff (Millwood)
|
2007
|
1.23
|
79
|
Income inequality and 30 day outcomes after acute myocardial infarction, heart failure, and pneumonia: retrospective cohort study.
|
BMJ
|
2013
|
1.23
|
80
|
Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy.
|
Circulation
|
2009
|
1.22
|
81
|
Door-to-drug and door-to-balloon times: where can we improve? Time to reperfusion therapy in patients with ST-segment elevation myocardial infarction (STEMI).
|
Am Heart J
|
2006
|
1.21
|
82
|
Time-to-reperfusion in patients undergoing interhospital transfer for primary percutaneous coronary intervention in the U.S: an analysis of 2005 and 2006 data from the National Cardiovascular Data Registry.
|
J Am Coll Cardiol
|
2008
|
1.19
|
83
|
Elevated admission glucose and mortality in elderly patients hospitalized with heart failure.
|
Circulation
|
2009
|
1.19
|
84
|
A high risk of hospitalization following release from correctional facilities in Medicare beneficiaries: a retrospective matched cohort study, 2002 to 2010.
|
JAMA Intern Med
|
2013
|
1.19
|
85
|
Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry.
|
J Am Coll Cardiol
|
2010
|
1.18
|
86
|
Development of 2 registry-based risk models suitable for characterizing hospital performance on 30-day all-cause mortality rates among patients undergoing percutaneous coronary intervention.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
1.17
|
87
|
Metformin and thiazolidinedione use in Medicare patients with heart failure.
|
JAMA
|
2003
|
1.15
|
88
|
Regional variation in cardiac catheterization appropriateness and baseline risk after acute myocardial infarction.
|
J Am Coll Cardiol
|
2008
|
1.14
|
89
|
Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies.
|
J Invasive Cardiol
|
2012
|
1.13
|
90
|
The relationship between systolic blood pressure on admission and mortality in older patients with heart failure.
|
Eur J Heart Fail
|
2010
|
1.12
|
91
|
Hospital-level performance improvement: beta-blocker use after acute myocardial infarction.
|
Med Care
|
2004
|
1.10
|
92
|
The prognostic value of E-cadherin in gastric cancer: a meta-analysis.
|
Int J Cancer
|
2012
|
1.09
|
93
|
Recent trends in hospitalization for acute myocardial infarction.
|
Am J Cardiol
|
2012
|
1.08
|
94
|
Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada.
|
Arch Intern Med
|
2005
|
1.05
|
95
|
Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®.
|
Pacing Clin Electrophysiol
|
2013
|
1.05
|
96
|
National patterns of risk-standardized mortality and readmission after hospitalization for acute myocardial infarction, heart failure, and pneumonia: update on publicly reported outcomes measures based on the 2013 release.
|
J Gen Intern Med
|
2014
|
1.04
|
97
|
Relation between hospital specialization with primary percutaneous coronary intervention and clinical outcomes in ST-segment elevation myocardial infarction: National Registry of Myocardial Infarction-4 analysis.
|
Circulation
|
2006
|
1.04
|
98
|
Delay in presentation and reperfusion therapy in ST-elevation myocardial infarction.
|
Am J Med
|
2008
|
1.04
|
99
|
Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project.
|
Diabetes Care
|
2005
|
1.02
|
100
|
Diagnosis and minimally invasive surgery for the pituitary abscess: a review of twenty nine cases.
|
Clin Neurol Neurosurg
|
2012
|
1.02
|
101
|
Quality of care of Medicare beneficiaries with acute myocardial infarction: who is included in quality improvement measurement?
|
J Am Geriatr Soc
|
2003
|
1.02
|
102
|
Comparing hospital performance in door-to-balloon time between the Hospital Quality Alliance and the National Cardiovascular Data Registry.
|
J Am Coll Cardiol
|
2007
|
1.01
|
103
|
Regional variation in the use of implantable cardioverter-defibrillators for primary prevention: results from the National Cardiovascular Data Registry.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
1.01
|
104
|
Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States.
|
Circ Cardiovasc Qual Outcomes
|
2011
|
0.98
|
105
|
Mental disorders, quality of care, and outcomes among older patients hospitalized with heart failure: an analysis of the national heart failure project.
|
Arch Gen Psychiatry
|
2008
|
0.97
|
106
|
Physician procedure volume and complications of cardioverter-defibrillator implantation.
|
Circulation
|
2011
|
0.95
|
107
|
Hospital-based, acute care use among patients within 30 days of discharge after coronary artery bypass surgery.
|
Ann Thorac Surg
|
2013
|
0.94
|
108
|
Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study.
|
Endocr J
|
2010
|
0.93
|
109
|
Impact of delay in door-to-needle time on mortality in patients with ST-segment elevation myocardial infarction.
|
Am J Cardiol
|
2007
|
0.92
|
110
|
Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry.
|
J Am Coll Cardiol
|
2010
|
0.92
|
111
|
Variation among hospitals in selection of higher-cost, "higher-tech," implantable cardioverter-defibrillators: data from the National Cardiovascular Data Registry (NCDR) Implantable Cardioverter/Defibrillator (ICD) Registry.
|
Am Heart J
|
2013
|
0.92
|
112
|
Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study.
|
BMJ
|
2003
|
0.91
|
113
|
DKK3 is a potential tumor suppressor gene in papillary thyroid carcinoma.
|
Endocr Relat Cancer
|
2013
|
0.91
|
114
|
Certificate of need regulation and cardiac catheterization appropriateness after acute myocardial infarction.
|
Circulation
|
2007
|
0.90
|
115
|
Use of remote monitoring of newly implanted cardioverter-defibrillators: insights from the patient related determinants of ICD remote monitoring (PREDICT RM) study.
|
Circulation
|
2013
|
0.90
|
116
|
Correlations among risk-standardized mortality rates and among risk-standardized readmission rates within hospitals.
|
J Hosp Med
|
2012
|
0.90
|
117
|
What are hospitals doing to increase beta-blocker use?
|
Jt Comm J Qual Saf
|
2003
|
0.87
|
118
|
The association of 6-minute walk performance and outcomes in stable outpatients with heart failure.
|
J Card Fail
|
2004
|
0.86
|
119
|
Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria?
|
Am Heart J
|
2009
|
0.86
|
120
|
The door-to-balloon alliance for quality: who joins national collaborative efforts and why?
|
Jt Comm J Qual Patient Saf
|
2009
|
0.86
|
121
|
Regional density of cardiologists and rates of mortality for acute myocardial infarction and heart failure.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
0.85
|
122
|
Lower hospital volume is associated with higher in-hospital mortality in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction: A report from the NCDR.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
0.84
|
123
|
Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: findings from the National Heart Failure Project.
|
Am Heart J
|
2005
|
0.84
|
124
|
Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the National Cardiovascular Data Registry.
|
J Am Heart Assoc
|
2012
|
0.84
|
125
|
US cardiologist workforce from 1995 to 2007: modest growth, lasting geographic maldistribution especially in rural areas.
|
Health Aff (Millwood)
|
2011
|
0.83
|
126
|
Who is missing from the measures? Trends in the proportion and treatment of patients potentially excluded from publicly reported quality measures.
|
Am Heart J
|
2010
|
0.83
|
127
|
Genome-wide identification of heat shock proteins (Hsps) and Hsp interactors in rice: Hsp70s as a case study.
|
BMC Genomics
|
2014
|
0.82
|
128
|
Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing?: an analysis of 107,096 patients from the National Cardiovascular Data Registry's ICD Registry.
|
J Am Coll Cardiol
|
2012
|
0.81
|
129
|
Prior aspirin use and outcomes in elderly patients hospitalized with acute myocardial infarction.
|
J Am Coll Cardiol
|
2005
|
0.81
|
130
|
Evaluation of protein phosphorylation site predictors.
|
Protein Pept Lett
|
2010
|
0.81
|
131
|
Predictors of cardiologist care for older patients hospitalized for heart failure.
|
Am Heart J
|
2004
|
0.80
|
132
|
Immuno-laser capture microdissection of frozen prolactioma sections to prepare proteomic samples.
|
Colloids Surf B Biointerfaces
|
2009
|
0.80
|
133
|
Contemporary evidence: baseline data from the D2B Alliance.
|
BMC Res Notes
|
2008
|
0.79
|
134
|
Bleeding-avoidance strategies and outcomes in patients ≥80 years of age with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the NCDR CathPCI Registry).
|
Am J Cardiol
|
2012
|
0.79
|
135
|
Determinants of cardiac catheterization use in older Medicare patients with acute myocardial infarction.
|
Circ Cardiovasc Qual Outcomes
|
2009
|
0.79
|
136
|
Effective performance of contrast enhanced SPACE imaging in clearly depicting the margin of pituitary adenoma.
|
Pituitary
|
2015
|
0.79
|
137
|
Quality of care for acute myocardial infarction in elderly patients with alcohol-related diagnoses.
|
Alcohol Clin Exp Res
|
2006
|
0.78
|
138
|
Age differences in primary prevention implantable cardioverter-defibrillator use in U.S. individuals.
|
J Am Geriatr Soc
|
2011
|
0.78
|
139
|
The value of an acute octreotide suppression test in predicting short-term efficacy of somatostatin analogues in acromegaly.
|
Endocr J
|
2016
|
0.78
|
140
|
Temporal trends in quality of care among recipients of implantable cardioverter-defibrillators: insights from the National Cardiovascular Data Registry.
|
Circulation
|
2013
|
0.78
|
141
|
Admission body temperature and mortality in elderly patients hospitalized for heart failure.
|
J Am Coll Cardiol
|
2006
|
0.77
|
142
|
Regional associations between Medicare Advantage penetration and administrative claims-based measures of hospital outcomes.
|
Med Care
|
2012
|
0.77
|
143
|
[Expression of CCDC67 mRNA and its role in patients with papillary thyroid carcinoma].
|
Zhonghua Yi Xue Za Zhi
|
2014
|
0.77
|
144
|
Development of a Hospital Outcome Measure Intended for Use With Electronic Health Records: 30-Day Risk-standardized Mortality After Acute Myocardial Infarction.
|
Med Care
|
2015
|
0.77
|
145
|
NBD-based fluorescent chemosensor for the selective quantification of copper and sulfide in an aqueous solution and living cells.
|
Org Biomol Chem
|
2015
|
0.77
|
146
|
Improvements in the distribution of hospital performance for the care of patients with acute myocardial infarction, heart failure, and pneumonia, 2006-2011.
|
Med Care
|
2015
|
0.76
|
147
|
Systolic function as a predictor of mortality and quality of life in long-term survivors with heart failure.
|
Clin Cardiol
|
2008
|
0.76
|
148
|
Recovery of HPA Axis Function After Successful Gonadotropin-Induced Pregnancy and Delivery in a Woman With Panhypopituitarism: Case Report and Review.
|
Medicine (Baltimore)
|
2015
|
0.75
|
149
|
A systematic review and meta-analysis of surgeries performed for treating deep-seated cerebral cavernous malformations.
|
Br J Neurosurg
|
2015
|
0.75
|
150
|
Long-term storage and subsequent reactivation of aerobic granules.
|
Bioresour Technol
|
2008
|
0.75
|
151
|
Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation.
|
Circ Cardiovasc Qual Outcomes
|
2011
|
0.75
|
152
|
Retinal nerve fiber layer changes after transsphenoidal and transcranial pituitary adenoma resection.
|
Pituitary
|
2016
|
0.75
|
153
|
Understanding the use and impact of the online community in a national quality improvement campaign.
|
BMJ Qual Saf
|
2011
|
0.75
|
154
|
Person reidentification by minimum classification error-based KISS metric learning.
|
IEEE Trans Cybern
|
2014
|
0.75
|
155
|
[Improved lipid productivity of Nannochloropsis by heavy-ion irradiation mutagenesis].
|
Sheng Wu Gong Cheng Xue Bao
|
2013
|
0.75
|
156
|
Impact of community wealth on use of cardiac-resynchronization therapy with defibrillators for heart failure patients.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
0.75
|
157
|
Gene expression profiling in human null cell pituitary adenoma tissue.
|
Pituitary
|
2007
|
0.75
|
158
|
Comparison of multifocal visual evoked potential, static automated perimetry, and optical coherence tomography findings for assessing visual pathways in patients with pituitary adenomas.
|
Pituitary
|
2015
|
0.75
|
159
|
[One case of bilateral chylothorax after cervical lymph node dissection in thyroid carcinoma].
|
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
|
2014
|
0.75
|